160 related articles for article (PubMed ID: 3142338)
1. Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens.
Panneton AC; Bergeron MG; LeBel M
Antimicrob Agents Chemother; 1988 Oct; 32(10):1515-20. PubMed ID: 3142338
[TBL] [Abstract][Full Text] [Related]
2. Penetration of fleroxacin and ciprofloxacin into skin blister fluid: a comparative study.
Lubowski TJ; Nightingale C; Sweeney K; Quintiliani R; Zhi J
Antimicrob Agents Chemother; 1992 Mar; 36(3):651-5. PubMed ID: 1622179
[TBL] [Abstract][Full Text] [Related]
3. Single and multiple dose pharmacokinetics of fleroxacin.
Weidekamm E; Portmann R; Partos C; Dell D
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():145-54. PubMed ID: 3144533
[TBL] [Abstract][Full Text] [Related]
4. Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans.
Weidekamm E; Portmann R; Suter K; Partos C; Dell D; Lücker PW
Antimicrob Agents Chemother; 1987 Dec; 31(12):1909-14. PubMed ID: 3125788
[TBL] [Abstract][Full Text] [Related]
5. Altered disposition of fleroxacin in patients with cystic fibrosis.
Mimeault J; Vallée F; Seelmann R; Sörgel F; Ruel M; LeBel M
Clin Pharmacol Ther; 1990 May; 47(5):618-28. PubMed ID: 2111750
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and body fluid penetration of fleroxacin in healthy volunteers.
Sorgel F; Metz R; Naber K; Seelmann R; Muth P
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():155-67. PubMed ID: 3144534
[TBL] [Abstract][Full Text] [Related]
7. Comparative oral pharmacokinetics of fleroxacin and pefloxacin.
De Lepeleire I; Van Hecken A; Verbesselt R; Tjandra-Maga TB; De Schepper PJ
J Antimicrob Chemother; 1988 Aug; 22(2):197-202. PubMed ID: 3141343
[TBL] [Abstract][Full Text] [Related]
8. Steady-state pharmacokinetics of fleroxacin in patients with skin and skin structure infections.
Heim-Duthoy K; Peltier G; Awni W
Antimicrob Agents Chemother; 1990 May; 34(5):922-3. PubMed ID: 2113797
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone.
Wise R; Kirkpatrick B; Ashby J; Griggs DJ
Antimicrob Agents Chemother; 1987 Feb; 31(2):161-3. PubMed ID: 3105446
[TBL] [Abstract][Full Text] [Related]
10. The comparative pharmacokinetics and tissue penetration of single-dose ciprofloxacin 400 mg i.v. and 750 mg po.
Catchpole C; Andrews JM; Woodcock J; Wise R
J Antimicrob Chemother; 1994 Jan; 33(1):103-10. PubMed ID: 8157550
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics and tolerance of fleroxacin in healthy male volunteers.
Nakashima M; Kanamaru M; Uematsu T; Takiguchi A; Mizuno A; Itaya T; Kawahara F; Ooie T; Saito S; Uchida H
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():133-44. PubMed ID: 3144532
[TBL] [Abstract][Full Text] [Related]
12. Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in elderly patients.
Taburet AM; Devillers A; Thomare P; Fillastre JP; Veyssier P; Singlas E
Clin Pharmacokinet; 1990 Jul; 19(1):80-8. PubMed ID: 2116257
[TBL] [Abstract][Full Text] [Related]
13. Penetration of fleroxacin into prostatic secretion and prostatic adenoma tissue.
Kees F; Naber KG; Schumacher H; Grobecker H
Chemotherapy; 1988; 34(6):437-43. PubMed ID: 2468456
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis.
Stuck AE; Frey FJ; Heizmann P; Brandt R; Weidekamm E
Antimicrob Agents Chemother; 1989 Mar; 33(3):373-81. PubMed ID: 2499248
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of free tissue concentrations of fleroxacin after oral administration.
Limberg J; LeBel M; Derendorf H
Pharm Res; 1990 Apr; 7(4):422-4. PubMed ID: 2114021
[No Abstract] [Full Text] [Related]
16. Penetration of fleroxacin into breast milk and pharmacokinetics in lactating women.
Dan M; Weidekamm E; Sagiv R; Portmann R; Zakut H
Antimicrob Agents Chemother; 1993 Feb; 37(2):293-6. PubMed ID: 8452360
[TBL] [Abstract][Full Text] [Related]
17. Influence of sex on the pharmacokinetic interaction of fleroxacin and ciprofloxacin with caffeine.
Kim MK; Nightingale C; Nicolau D
Clin Pharmacokinet; 2003; 42(11):985-96. PubMed ID: 12908854
[TBL] [Abstract][Full Text] [Related]
18. Single-dose pharmacokinetics of oral fleroxacin in bacteremic patients.
Schrenzel J; Cerruti F; Herrmann M; Leemann T; Weidekamm E; Portmann R; Hirschel B; Lew DP
Antimicrob Agents Chemother; 1994 Jun; 38(6):1219-24. PubMed ID: 8092817
[TBL] [Abstract][Full Text] [Related]
19. Penetration of fleroxacin into body tissues and fluids.
Weidekamm E; Portmann R
Am J Med; 1993 Mar; 94(3A):75S-80S. PubMed ID: 8452186
[TBL] [Abstract][Full Text] [Related]
20. Difference in blister fluid penetration after single and multiple doses of ceftriaxone.
LeBel M; Grégoire S; Caron M; Bergeron MG
Antimicrob Agents Chemother; 1985 Jul; 28(1):123-7. PubMed ID: 4037771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
